SEC Form 4 · accession 0001493152-18-009767

ONCOSEC MEDICAL Inc · ONCS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jun 15, 2018

Accepted (ET)

Jul 6, 2018 · 4:40 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001444307

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jun 15, 2018	M	100,000	—	A	181,002	D
Common Stock^F2	Jun 18, 2018	S	5,552	$1.386	D	175,450	D
Common Stock^F2	Jun 19, 2018	S	1,838	$1.364	D	173,612	D
Common Stock^F2	Jun 20, 2018	S	10,973	$1.422	D	162,639	D
Common Stock^F2	Jun 21, 2018	S	2,178	$1.401	D	160,461	D
Common Stock^F2	Jun 22, 2018	S	2,956	$1.418	D	157,505	D
Common Stock^F2	Jun 25, 2018	S	202	$1.405	D	157,303	D
Common Stock^F2	Jun 26, 2018	S	4,703	$1.398	D	152,600	D
Common Stock^F2	Jun 27, 2018	S	3,451	$1.374	D	149,149	D
Common Stock^F2	Jun 28, 2018	S	1,556	$1.401	D	147,593	D
Common Stock^F2	Jun 29, 2018	S	1,066	$1.38	D	146,527	D
Common Stock^F2	Jul 5, 2018	S	3,100	$1.312	D	143,427	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1	—	Jun 15, 2018	M	100,000	D	Mar 4, 2019	Mar 4, 2019	Common Stock	100,000	0	D

F1Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
F2Sale to cover taxes on restricted stock unit vesting.